Hwang In-Chang, Choi Sol Ji, Choi Ji Eun, Ko Eun-Bi, Suh Jae Kyung, Choi Insun, Kang Hyun-Jae, Kim Yong-Jin, Kim Joo Youn
Cardiovascular Center and Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea.
Clin Cardiol. 2017 Nov;40(11):1129-1138. doi: 10.1002/clc.22799. Epub 2017 Sep 15.
Controversies remain regarding clinical outcomes following initial strategies of coronary computed tomography angiography (CCTA) vs usual care with functional testing in patients with suspected coronary artery disease (CAD).
CCTA as initial diagnostic strategy results in better mid- to long-term outcomes than usual care in patients with suspected CAD.
We searched PubMed, Embase, and Cochrane Library for randomized controlled trials comparing clinical outcomes during ≥6 months' follow-up between initial anatomical testing by CCTA vs usual care with functional testing in patients with suspected CAD. Occurrence of all-cause mortality, nonfatal myocardial infarction (MI), and major adverse cardiovascular events (MACE), and use of invasive coronary angiography and coronary revascularization, were compared between the 2 diagnostic strategies.
Twelve trials were included (20 014 patients; mean follow-up, 20.5 months). Patients undergoing CCTA as initial noninvasive testing had lower risk of nonfatal MI compared with those treated with usual care (risk ratio [RR]: 0.70, 95% confidence interval [CI]: 0.52-0.94, P = 0.02). There was a tendency for reduced MACE following initial CCTA strategy, but not for risk of all-cause mortality. Compared with functional testing, the CCTA strategy increased use of invasive coronary angiography (RR: 1.53, 95% CI: 1.12-2.09, P = 0.007) and coronary revascularization (RR: 1.49, 95% CI: 1.11-2.00, P = 0.007).
Anatomical testing with CCTA as the initial noninvasive diagnostic modality in patients with suspected CAD resulted in lower risk of nonfatal MI than usual care with functional testing, at the expense of more frequent use of invasive procedures.
对于疑似冠状动脉疾病(CAD)患者,冠状动脉计算机断层扫描血管造影(CCTA)初始策略与功能测试常规治疗后的临床结局仍存在争议。
在疑似CAD患者中,CCTA作为初始诊断策略比常规治疗能带来更好的中长期结局。
我们检索了PubMed、Embase和Cochrane图书馆,以查找比较疑似CAD患者中CCTA初始解剖学测试与功能测试常规治疗在≥6个月随访期间临床结局的随机对照试验。比较了两种诊断策略之间全因死亡率、非致命性心肌梗死(MI)和主要不良心血管事件(MACE)的发生情况,以及有创冠状动脉造影和冠状动脉血运重建的使用情况。
纳入了12项试验(20014例患者;平均随访20.5个月)。与接受常规治疗的患者相比,以CCTA作为初始非侵入性测试的患者发生非致命性MI的风险更低(风险比[RR]:0.70,95%置信区间[CI]:0.52 - 0.94,P = 0.02)。初始CCTA策略后MACE有降低趋势,但全因死亡率风险没有降低。与功能测试相比,CCTA策略增加了有创冠状动脉造影(RR:1.53,95%CI:1.12 - 2.09,P = 0.007)和冠状动脉血运重建(RR:1.49,95%CI:1.11 - 2.00,P = 0.007)的使用。
在疑似CAD患者中,以CCTA作为初始非侵入性诊断方式的解剖学测试导致非致命性MI风险低于功能测试常规治疗,但代价是更频繁地使用侵入性操作。